2014 Melanoma Treatment Advances

January 3, 2015

Review topics

"In 2014, treatment in melanoma has never been so promising, and immunotherapies are delivering durable benefit", according to the review authors.

The most notable advances are outlined within the following sections:

• Single-Agent PD-1 Inhibition
• Combination Immunotherapy Sends Survival to a New Level
• BRAF/MEK Combo: Likely New Standard of Care
• 'Long Duration of Survival in Reach for Any Patient'

Professor Ribas will be one of the featured speakers at the Melanoma Summit to be held in Auckland 6-7 November 2015.

Source:

Melanoma 2014: Another Banner Year
Antoni Ribas, MD, PhD, Nancy Terry December 18, 2014
http://www.medscape.com/viewarticle/836667#vp_1